124 related articles for article (PubMed ID: 1226572)
1. [Effects of Hodgkin cytotoxic serum on blast transformation of normal and Hodgkin human peripheral blood lymphocytes].
Tognella S; Mantovani G; Del Giacco GS; Manconi PE; Cengiarotti L; Floris C; Grifoni V
Tumori; 1975; 61(1):53-62. PubMed ID: 1226572
[TBL] [Abstract][Full Text] [Related]
2. [Effects of Hodgkin cytotoxic serum on electrophoretic mobility of normal and Hodgkin peripheral blood lymphocytes. (author's transl)].
Tognella S; Mantovani G; Cengiarotti L; Del Giacco GS; Manconi PE; Grifoni V
Tumori; 1975; 61(1):45-52. PubMed ID: 1084065
[TBL] [Abstract][Full Text] [Related]
3. [In vitro development of macrophages from PHA-stimulated blood cultures in Hodgkin's disease and in chronic lymphocytic leukaemia (author's transl)].
Navone R; Tosto M; Poggio E
Tumori; 1976; 62(1):19-24. PubMed ID: 1014113
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic activity of lymphocytes from patients with Hodgkin's disease.
Holm G; Björkholm M; Mellstedt H; Johansson B
Clin Exp Immunol; 1975 Sep; 21(3):376-83. PubMed ID: 1081933
[TBL] [Abstract][Full Text] [Related]
5. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
Pappas A; Pees H; Girmann G
Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
[TBL] [Abstract][Full Text] [Related]
6. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
7. Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.
Fuks Z; Strober S; King DP; Kaplan HS
J Immunol; 1976 Oct; 117(4):1331-5. PubMed ID: 1086325
[TBL] [Abstract][Full Text] [Related]
8. The lymphocyte response in Hodgkin's disease.
Braeman J; Evans IH; Deeley TJ
Clin Radiol; 1975 Jul; 26(3):305-9. PubMed ID: 1081440
[TBL] [Abstract][Full Text] [Related]
9. Binding of phytohaemagglutinin to serum substances and inhibition of lymphocyte transformation in Hodgkin's disease.
Amlot PL; Unger A
Clin Exp Immunol; 1976 Dec; 26(3):520-7. PubMed ID: 1009684
[TBL] [Abstract][Full Text] [Related]
10. [Comparative studies of the proportions of T, B and O-lymphocytes and of the degree of blastic transformation following stimulation with PHA in patients with Hodgkin's disease].
Pluzańska A
Pol Arch Med Wewn; 1977 Apr; 57(4):297-305. PubMed ID: 300871
[No Abstract] [Full Text] [Related]
11. Comparative studies of the proportions of T, B and zero lymphocytes and the degrees of blastic transformation of lymphocytes after stimulation by PHA and CON A in patients with Hodgkin's disease.
Pluzańska A
Haematol Blood Transfus; 1977; 20():203-7. PubMed ID: 305396
[No Abstract] [Full Text] [Related]
12. Hodgkin's disease: response of lymphocytes to PHA.
Sforza MB; De Somoza N; Morgenfeld CM
Sangre (Barc); 1971; 16(3):300-4. PubMed ID: 5120513
[No Abstract] [Full Text] [Related]
13. In vitro lymphocyte dysfunction in Hodgkin's disease.
Graze PR; Perlin E; Royston I
J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
[TBL] [Abstract][Full Text] [Related]
14. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
15. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
Rambotti P; Velardi A; Spinozzi F; Falini B; Martelli MF
Boll Ist Sieroter Milan; 1979 Mar; 58(1):90-9. PubMed ID: 552840
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.
Bobrove AM; Fuks Z; Strober S; Kaplan HS
Cancer; 1975 Jul; 36(1):169-79. PubMed ID: 54208
[TBL] [Abstract][Full Text] [Related]
17. [T and B lymphocytes in chronic lymphocytic leukemia and Hodgkin's disease. Electron microscopic and immunologic studies].
Cohnen G
Veroff Pathol; 1975; (0):1-99. PubMed ID: 49138
[TBL] [Abstract][Full Text] [Related]
18. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease.
Land JM; Litwin J; Bigel P; Oberling F; Mayer S
Acta Haematol Pol; 1977; 8(2):131-4. PubMed ID: 329629
[TBL] [Abstract][Full Text] [Related]
19. Absence of IgG lymphocytotoxins in untreated Hodgkin's disease (HD) patients.
Jones DB; Elliott EV; Payne SV; Wright DH
Clin Exp Immunol; 1978 Oct; 34(1):100-5. PubMed ID: 750114
[TBL] [Abstract][Full Text] [Related]
20. Impairment of lymphocyte transformation by plasma from patients with advanced Hodgkin's disease.
Sugden PJ; Lilleyman JS
Cancer; 1980 Mar; 45(5):899-905. PubMed ID: 7260841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
